Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05215769 · ClinicalTrials.gov registry record · NA
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer
A NA study of Metastatic Malignant Solid Neoplasm and Stage IV Lung Cancer AJCC v8, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 243
- Enrollment target
- 4
- Study locations
NCT05215769: Active NA study of Metastatic Malignant Solid Neoplasm and Stage IV Lung Cancer AJCC v8, sponsored by Ohio State University Comprehensive Cancer Center.
NCT05215769 is a NA study of Metastatic Malignant Solid Neoplasm and Stage IV Lung Cancer AJCC v8 that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 243 participants, above the 204-participant average among 92 other Metastatic Malignant Solid Neoplasm trials with a reported enrollment target (19% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05215769, a NA study of Metastatic Malignant Solid Neoplasm and Stage IV Lung Cancer AJCC v8, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 243 participants
- Enrollment target
- 4
- Study locations
Study Summary
This clinical trial tests whether a video intervention improves patient understanding of tumor genomic testing in patients with cancer that has spread to other parts of the body (metastatic). Measuring how the video intervention affects patient understanding of tumor genomic testing in patients with metastatic cancer may help doctors provide patient-centered care by effectively communicating the importance of tumor genomic testing.
Primary Outcome
Measured as percentage correct out of 10 questions. Will have 90% power to detect an effect size of 0.47 in change of recall accuracy from pre- to post- video intervention, using a two-sided Wilcoxon signed-rank test with alpha of 0.05.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- BEHAVIORAL Health Education
Study Locations (4)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
- St. Rita's - Lima
- Saint Francis Medical Center - Richmond
- Saint Elizabeth Youngstown Hospital - Youngstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2022-03-30 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT05215769 still lists
NCT05215769 is an interventional study that assigns participants to a tested intervention. The registered 243 participants enrollment target is mid-sized for trials with a published cap, above the 204-participant average among 92 other Metastatic Malignant Solid Neoplasm trials with a reported enrollment target (19% higher).
The record links to 8 conditions, with Metastatic Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT05215769 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05215769 about?
NCT05215769 is a clinical study titled "A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer". This clinical trial tests whether a video intervention improves patient understanding of tumor genomic testing in patients with cancer that has spread to other parts of the body (metastatic). Measuring how the video intervention affects patient understanding of tumor genomic testing in patients with...
What is the current status of trial NCT05215769?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 243 participants. The study started on 2022-03-30. Estimated completion is 2026-07-31.
What conditions does trial NCT05215769 study?
This clinical trial studies the following conditions: Metastatic Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8.
What interventions are being tested in trial NCT05215769?
The interventions under investigation include: Questionnaire Administration (OTHER), Health Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT05215769?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05215769 being conducted?
This trial has 4 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05215769's enrollment target sits among peer trials
243 11th of 92 higher than 82 of 92 other Metastatic Malignant Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metastatic Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors
RECRUITING · NA
-
Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
RECRUITING · NA
-
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
RECRUITING · NA
-
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
RECRUITING · NA
-
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
RECRUITING · NA
-
Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06253871 · 243 participants · Phase 1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NCT06289491 · 243 participants · NA
A Trial of Hydrus Microstent Versus Goniotomy
- NCT06536296 · 243 participants · NA
The Impact of Music Medicine on Preterm Brain Development and Behavior
- NCT06907615 · 243 participants · Phase 2
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI